IDT and Aldevron launch Cas9 mRNA for CRISPR gene editing research
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development
September 16, 2026 8:03 AM EDTCo-developed offering connects Integrated DNA Technologies CRISPR engineering and analysis expertise with Aldevrons mRNA manufacturing capabilities, helping customers move from discovery toward clinical development with greater speed, continuity, and confidence.Research grade S.p. Cas9 mRNA is available in wild type and SpyFi high-fidelity formats to support CRISPR-based research applications.Optimized mRNA constructs are designed for high on-target editing, reduced off-target activity with SpyFi, low toxicity, and delivery method flexibility.
FARGO, N.D. & CORALVILLE, Iowa--(BUSINESS WIRE)-- Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics,... More



